Category Archives: HGH

Abstract Leber congenital amaurosis (LCA), one of the leading causes of childhood-onset blindness, is caused by autosomal recessive mutations in several genes including RPE65. In this study, we performed CRISPR-Cas9mediated therapeutic correction of a disease-associated nonsense mutation in Rpe65 in rd12 mice, a model of human LCA. Subretinal injection of adeno-associated virus carrying CRISPR-Cas9 and donor DNA resulted in > 1% homology-directed repair and ~1.6% deletion of the pathogenic stop codon in Rpe65 in retinal pigment epithelial tissues of rd12 mice. Continue reading →

MIAMI, Nov. 01, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc Continue reading →

The facility lies midway between Munichs city center and its international airport, roughly 23 miles to the north. From the outside, it still looks like the state-run farm it once was, but peer through the windows of the old farmhouse and youll see rooms stuffed with cutting-edge laboratory equipment. Continue reading →

The Anal Irrigator Market report studies, analyzes and researches the growth status that are estimated in the regions such as North America, Asia Pacific, Europe, the Middle East & Africa and Latin America. Along with this, the research report also includes an analysis of the current progresses and future plans of the firms in order to comprehend the course of the players in the near future. The report also gives a deep outline of the drivers, restraints, opportunities and competitive landscape analysis Continue reading →

Detailed research report on the Human Growth Hormone market helps the readers to explore the market growth trend in the future and subsequently make correct business-related decisions. Continue reading →

SHANGHAI, Oct. 25, 2019 /PRNewswire/ --VISEN Pharmaceuticals, a company focused on the treatment of endocrine-related diseases, announced today the approval of a new drug (IND) application with the China National Drug Administration (NMPA) to initiate a phase 3 study for TransCon human growth hormone (TransCon hGH) with childhood growth hormone deficiency (GHD). TransCon hGH is expected to be the first long-acting growth hormone (LAGH) therapy in China that releases unmodified growth hormone, the same growth hormone used in daily therapies, with convenient once weekly dosing. Continue reading →

Opko Health Inc. shares OPK, -11.66% soared 21% in premarket trade Monday, while Pfizer Inc Continue reading →

The Global Human Growth Hormone market is valued at million US$ in 2018 is relied upon to arrive at million US$ before the finish of 2024, developing at a CAGR of during 2019-2024. The Human Growth Hormone market report provides an unbiased and detailed analysis of the on-going patterns, openings/high development regions, advertise drivers, which would help partners to device and adjust market methodologies as per the present and future market dynamics. The Human Growth Hormone market report thoroughly covers the market by product device, deployment, verticals and countries Continue reading →

DUBLIN--(BUSINESS WIRE)--The "United States Biosimilar Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering. The country research report on the United States biosimilar market is a customer intelligence and competitive study of the United States market Continue reading →

MIAMI, Oct. Continue reading →